ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Neuro-regenerative imidazole-functionalized GelMA hydrogel loaded with hAMSC and SDF-1α promote stem cell differentiation and repair focal brain injury

Zheng, Yantao; Wu, Gang; Chen, Limei; Zhang, Ying; Luo, Yuwei; Zheng, Yong; Hu, Fengjun; Forouzanfar, Tymor; Lin, Haiyan*; Liu, Bin*南方医科大学
Bioactive Materials2021-3DOI: 10.1016/j.bioactmat.2020.08.026
42被引16阅读
引用收藏
分享

摘要

Brain tissues that are severely damaged by traumatic brain injury (TBI) is hardly regenerated, which leads to a cavity or a repair with glial scarring. Stem-cell therapy is one viable option to treat TBI-caused brain tissue damage, whose use is, whereas, limited by the low survival rate and differentiation efficiency of stem cells. To approach this problem, we developed an injectable hydrogel using imidazole groups-modified gelatin methacrylate (GelMA-imid). In addition, polydopamine (PDA) nanoparticles were used as carrier for stromal-cell derived factor-1 (SDF-1 alpha). GelMA-imid hydrogel loaded with PDA@SDF-1 alpha nanoparticles and human amniotic mesenchymal stromal cells (hAMSCs) were injected into the damaged area in an in-vivo cryogenic injury model in rats. The hydrogel had low module and its average pore size was 204.61 +/- 41.41 nm, which were suitable for the migration, proliferation and differentiation of stem cells. In-vitro cell scratch and differentiation assays showed that the imidazole groups and SDF-1 alpha could promote the migration of hAMSCs to injury site and their differentiation into nerve cells. The highest amount of nissl body was detected in the group of GelMA-imid/SDF1 alpha/hAMSCs hydrogel in the in-vivo model. Additionally, histological analysis showed that GelMA-imid/SDF-1 alpha/ hAMSCs hydrogel could facilitate the regeneration of regenerate endogenous nerve cells. In summary, the GelMA-imid/SDF-1 alpha/hAMSCs hydrogel promoted homing and differentiation of hAMSCs into nerve cells, and showed great application potential for the physiological recovery of TBI.

学科与关键词

关键词
Injectable hydrogelImidazoleStromal-cell derived factor-1 (SDF-1 alpha)Human amniotic mesenchymal stromal cells (hAMSCs)Brain injury
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Bioactive Materials
发表日期
2021-03
卷期
第 6 卷, 第 3 期
页码
627-637
DOI
10.1016/j.bioactmat.2020.08.026
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
Science and Technology Project of Guangdong Province [2015A020212021]; Medical Health Science and Technology Project of Zhejiang Provincial Health Commission [2020KY625]; Zhejiang Provincial Department of Education [Y201636248]; Natural Science Foundation of Zhejiang Province [LQY17H140023]; Science Technology Department of Zhejiang Province [2017C33168]; Zhejiang Provincial Basic Public Welfare Research Project [GJ19H140001]; China's National Key RD Programs [2018YFB0407204]

作者

  • Z

    Zheng, Yantao (第一作者)

  • W

    Wu, Gang

查看全部 10 位作者收起作者
  • C

    Chen, Limei

  • Z

    Zhang, Ying

  • L

    Luo, Yuwei

    southern med univ

  • Z

    Zheng, Yong

  • H

    Hu, Fengjun

    zhejiang shuren univ

  • F

    Forouzanfar, Tymor

  • L

    Lin, Haiyan (通讯)

  • L

    Liu, Bin (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417